Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.

Sorry, there's nothing here.

Topics

Cite this paper

@article{Hemrajani2007UseOS, title={Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.}, author={Reena H Hemrajani and Kevin B S Kim and Warren R. Amos and David E. Mann}, journal={Melanoma research}, year={2007}, volume={17 4}, pages={257-9} }